Cooper Companies | COO - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Align Technology USD 1.91B 2.74M 2026-06
AtriCure USD 81.92M 8.72M 2026-06
Bausch Health Companies USD 4.54B 14M 2026-06
Baxter International USD 3.59B 102M 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Cooper Companies USD 1.8B 209M 2026-03
Dentsply International USD 1.18B 22M 2026-06
Dexcom USD 2.36B 133.9M 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Globus Medical USD 479.35M 3.12M 2026-06
Haemonetics USD 263.24M 19.36M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 744.2M 56.7M 2026-06
Integra LifeSciences USD 330.88M 15.96M 2026-06
Intuitive Surgical USD 2.58B 65.1M 2026-06
J&J USD 54.9B 2.82B 2026-06
Medtronic USD 11.66B 2.16B 2026-03
Merit Medical Systems USD 264.93M 48.06M 2026-06
Novartis USD 31.37B 4.1B 2026-03
ResMed USD 1.4B 43.9M 2026-06
STAAR Surgical USD 73.39M 12.4M 2026-06
Steris USD 1.28B 138.3M 2026-06
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
Utah Medical Products USD 3.5M 907K 2026-03
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06